Optimal parameters for Gene Xpert MTB/RIF and LAM Strip determine Test for Diagnosis of Tuberculosis using urine from HIV patients at Moi Teaching and Referral Hospital, Kenya

Title: Optimal parameters for Gene Xpert MTB/RIF and LAM Strip determine Test for Diagnosis of Tuberculosis using urine from HIV patients at Moi Teaching and Referral Hospital, Kenya

Authors: Iddah. M. Ali, Gideon A. Ng’wena, Benard. O. Guyah, Kennedy K. Mutai, Benard. O. Abong’o

DOI: http://dx.doi.org/10.18535/jmscr/v3i8.16

DIDS : 08.2015-79323163

Abstract

References

Corresponding Author

Abstract

The application of Gene Xpert MTB/RIF®assay for testing non-sputum clinical samples in Western Kenya has not been reported. We are reporting on use of Zn, CD4 count, Hb, Creatinine, Proteinuria, and Hematuria as optimal parameters for Gene Xpert MTB/RIF and LAM Strip determine Test for diagnosis of tuberculosis.Urine from HIV/TB co-infected adults (n=158) with CD4+ count <200 cells/mm³was analyzed for mycobacteria tuberculosis DNA. Acid fast-staining, culture, clinical symptoms, laboratory and radiological findings were also assessed. Acid fast staining(55%) were TB positive, however, Gene Xpert test revealed 17(11%) of the patients were TB positive with 94% and 6% being MTB detected low and medium, respectively. Rifampicin resistance was not detected in 88% of the TB Gene Xpert positive patients with the remaining (12%) being indeterminate. LAM test revealed that 28% of the patients were TB positive. Radiology revealed that 45% of the patients had infiltrates. Presence of protein or blood in urine was significantly associated with TB positivity based on LAM strip determine test (48% vs 24%; p-value=0.021). The weighted kappa coefficient was 0.48 (95% CI 0.32-0.63; exact p-value <0.0001).The findings of this study show that urine Xpert MTB/RIF®can be used for diagnosis of TB using urine and taking Zn, CD4 count, Proteinuria, and Hematuria as optimal parameters.

Keywords:Urine,mycobacterium, Proteinuria, Hematuria, HIV Infection

References

1. WHO. TB/HIV facts 2012-2013. Accessed 09^th June 2015. Available at www.who.int/hiv/topics/tbhiv_facts_2013/en/

2. WHO. (2011)Rapid Implementation of the XpertMTB/RIF Diagnostic Test. Publication number WHO/HTM/TB/2011.2.2. World Health Organization, Geneva, Switzerland.

3. Moore D. L. C., Ekwaru P, Were W, Mwima G. and Solberg P. (2007) Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS21,713–719.

4. Boehme C.C., Hillemann D, Nicol M.P., ShenaiS,and (2010)Krapp F. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N Engl J. Med363,1005–1015.

5. Dawson R, M. P., Edwards D.J., Bateman E.D., Bekker L.G., and Wood R. (2010) Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int. J.Tuberc Lung Dis14(14),52–18.

6. Lawn S.D., Vogt M.and Wood R. (2012) Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis12, 201-209.

7. Monkongdee P. M. K., Cain K.P., Tasaneeyapan T, Nguyen H.D. and Nguyen T.N. (2009) Yield of acid fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J RespirCrit Care Med180,903-908.

8. Reid M.J. S. N. (2009). Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis9, 173–184.

9. Green C. H. J., Talbot E, Mwaba P, Reither K. and Zumla A.I. (2009) Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods. Lancet Infect Dis 9,505-511.

10. Hillemann D, R.-G. S., Boehme C. and Richter E. (2011) Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System. J. Clin. Microbiol49,1202–1205.

11. Boehme C.C., Nabeta P, Michael J.S., and Gotuzzo E. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet377, 1495-1505.

12. Lawn S.D., Vogt M, Ghebrekristos Y, Whitelaw A. and Wood R. (2012) Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis54(8), 1071-1079.

13. Peter J.G., van Zyl-Smit R, Haripersad A. andMottay L. (2012) Diagnostic accuracy of a urine LAM strip-test for TB detection in HIV-infected hospitalised patients. The European Resp. J. 40(5),1211 1220.

14. Wilson, D., Nachega, J,Morroni, C, Chaisson, R. and Maartens, G. (2006) Diagnosing smearnegative tuberculosis using case definitions and treatment response in HIV-infected adults. Int J Tuberc Lung Dis10(1), 31-38.

15. van Cleeff, M.R., Kivihya-Ndugga,L.E., Meme, H. Odhiambo, J.A.andKlatser, P.R. (2005) The role and performance of chest X-ray for the diagnosis of tuberculosis: a cost effectiveness analysis in Nairobi, Kenya. BMC Infect Dis5,111.

16. Klatt E.C., Nichols L. and Noguchi T.T. (1994) Evolving trends revealed by autopsies of patients with AIDS. Arch Pathol Lab Med 118, 884-890.

17. Havlir D.V. Barnes P.F. (1999) Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 340,367-373.

18. Herman E.S.andKlotman P.E. (2003) HIV-associated nephropathy: epidemiology, pathogenesis, and treatment. SeminNephrol23, 200-2008.

19. Kimmel P.L., Phillips T.M., Ferreira-Centeno A, Farkas-Szallasi T, Abraham A.A. and Garrett C.T. (1993) HIV-associated immune-mediated renal disease. Kidney Int44, 1327-1340.

Abstract

References

Corresponding Author

Call For Paper Volume 12 Issue 10 November 2024

JMSCR Menu

Impact Factor SJIF 2024: 7.892

Crossref - DOI

Editorial Policy

Frequency of Publication

Submission of Articles

Search